Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature

Leuk Lymphoma. 2021 May;62(5):1271-1274. doi: 10.1080/10428194.2020.1855343. Epub 2020 Dec 4.

Gemma Reynolds¹, Tamasine Stewart², Simon J Harrison^{2

3}, Andrew Spencer⁴, Benjamin W Teh^{1

3

5}

¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
² Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁴ Department of Malignant Haematology and Stem Cell Transplantation, Alfred Health, Melbourne, Australia.
⁵ National Centre for Infections in Cancer, Melbourne, Australia.

No abstract available

Publication types